Submitted by: Submitted by HexaReport
Views: 10
Words: 1066
Pages: 5
Category: Business and Industry
Date Submitted: 05/15/2016 11:58 PM
Hexa Reports
Market Research Reports and Insightful Company Profiles
Breast Cancer Therapeutics in Major Developed Market
Size, Share, Growth, Treatment, Analysis, Symptoms,
Emerging Trends and Opportunities to 2021
Breast Cancer Therapeutics in Major Developed Markets to 2021 - Growth Driven by Rapid Uptake of
Premium Priced Biologics and Rising Incidence
Summary
Breast cancer, a malignant neoplasm, is the second most common cancer and the most common cancer
in women worldwide, accounting for 16% of all female cancers, making the disease exceedingly
prevalent. The number of women diagnosed with breast cancer has increased over the past few
decades, but the number of deaths has declined due to earlier diagnosis and better treatment options.
Browse Detail Report With TOC @ http://www.hexareports.com/report/breast-cancer-therapeuticsin-major-developed-markets/details
Breast cancer treatment has been revolutionized in the past four decades, especially with increasing
usage of targeted therapies. The marketed products landscape comprises a wide range of treatment
options, including hormonal therapies, chemotherapies, combination therapies, and targeted therapies.
Nevertheless, significant unmet need remains for products that can improve overall survival rate, time
to disease progression, and overall response.
Hexa Reports
Market Research Reports and Insightful Company Profiles
Scope
The current breast cancer market contains novel products, including Perjeta, a targeted therapy;
Kadcyla, a human antibody-drug conjugate; and Halaven, a novel chemotherapeutic agent.
What are the competitive advantages of the existing novel drugs?
With over 700 active pipeline molecules, most of the investigational drug candidates are being
evaluated for the first-line or second-line treatment of advanced-stage breast cancer, featuring
new combination therapies, targeted therapies, and promising immunotherapies, as well as
chemotherapy drug candidates....